医療用ガスおよび機器市場規模、シェア、動向、2031年までの世界予測

世界の医療用ガスおよび機器市場は、予測期間中に年平均成長率（CAGR）6.2%で推移し、2025年の210億3,000万米ドルから2031年には300億5,000万米ドルに達するとMarketsandMarketsでは予測しています。

医療用ガスおよび関連機器の市場は、堅調な成長を続けています。これは主に、世界中の医療現場において、呼吸器ケア、クリティカルケア（重症患者管理）、および外科手術に対する需要が増加していることによるものです。COPD（慢性閉塞性肺疾患）、喘息、心血管疾患といった慢性疾患の有病率の上昇や高齢者人口の増加に伴い、医療用ガスおよび関連する供給機器への依存度が著しく高まっています。さらに、特に発展途上国における病院施設、外来手術センター、在宅医療サービスの整備や改修が進むことで、医療用ガスインフラの新規導入や設備の更新が促進されています。加えて、ガス供給システム、携帯型機器、モニタリング・ソリューションの技術革新が、治療効率の向上や医療アクセスの改善をもたらしています。こうした要因が相まって、医療用ガスおよび関連機器市場の継続的な成長を後押ししています。

調査の対象範囲：

本レポートは、医療用ガスおよび機器市場を分析し、種類、用途、エンドユーザー、地域といった各セグメントにおける市場規模と将来の成長性を推定することを目的としています。また、主要企業の競合分析に加え、各社の企業概要、提供サービス、最近の動向、主要な市場戦略についても取り上げています。

本レポートを購入すべき理由

本レポートは、医療用ガスおよび機器市場における既存の有力企業や新規参入企業に対し、市場全体の収益に関する極めて精度の高い推定値を提供します。ステークホルダーは、本レポートを通じて競争環境を把握し、自社の事業をより効果的に位置づけ、適切な市場参入戦略を策定するための知見を得ることができます。さらに、市場の動向を理解する一助となるほか、市場を牽引する要因（ドライバー）、阻害要因、課題、および機会に関する情報も提供します。

本レポートでは、以下の点に関する知見を提供します。

主要な促進要因（医療用酸素の需要増、手術件数の増加、高齢者人口の拡大、在宅医療への需要増）、阻害要因（呼吸器療法に対する診療報酬の引き下げ、世界的なヘリウム不足）、機会（ヘルスケア産業の拡大、疼痛管理への需要増、医療技術の進歩）、および課題（医療用ガスの供給制限、医療用ガス機器の高コスト）の分析。

• 市場浸透：世界の医療用ガスおよび機器市場における主要企業の製品に関する詳細情報。タイプ、用途、エンドユーザー、地域別の各種セグメントを網羅しています。
• 製品の改良・革新：世界の医療用ガスおよび機器市場における新製品の投入や、今後のトレンドに関する包括的な情報。
• 市場開拓：製品、用途、エンドユーザー、地域別に見た、収益性の高い成長市場に関する詳細な分析と知見。
• 市場の多角化：世界の医療用ガスおよび機器市場における新製品投入、市場拡大、最新の技術進歩、投資動向に関する包括的な情報。
• 競争状況の評価：世界の医療用ガスおよび機器市場における主要競合企業の市場シェア、成長戦略、製品ラインナップ、および供給能力に関する詳細な評価。

Report Description

The global medical gas and equipment market is projected to reach USD 30.05 billion by 2031 from USD 21.03 billion in 2025, at a CAGR of 6.2% during the forecast period.

The medical gas and equipment market is witnessing consistent growth. This is largely due to increased demand for respiratory care, critical care, and surgical procedures across healthcare systems worldwide. The rising prevalence of chronic diseases such as COPD, asthma, and cardiovascular disorders, along with a growing elderly population, has significantly increased dependence on medical gases and related delivery equipment. Moreover, the development and refurbishment of hospital buildings, ambulatory surgical centers, and home healthcare services, especially in developing countries, are leading to new medical gas infrastructure installations and upgrades. Furthermore, innovations in gas delivery systems, portable devices, and monitoring solutions are revolutionizing treatment efficiency and making care more accessible. Together, these factors are driving continued growth in the medical gas and equipment market.

“By type, the medical gases segment is expected to have the largest market share in the medical gas and equipment market.”

Medical gases represent the largest segment in the medical gas and equipment market by type, owing to their indispensable and constant use across nearly all healthcare settings. Gases such as oxygen, medical air, nitrous oxide, nitrogen, and carbon dioxide play a vital role in respiratory therapy, anesthesia, intensive care, emergency treatment, and a wide range of diagnostic and therapeutic procedures. While equipment is purchased or replaced on a one-time basis, medical gases are consumables that require a regular supply; hence, demand for them is consistently high. The escalating number of chronic disease cases, increasing surgical procedures, and rising hospital and ICU admissions continue to fuel medical gas consumption. Furthermore, the growth of home healthcare and long-term oxygen therapy, coupled with stringent regulatory requirements that guarantee uninterrupted gas availability in healthcare facilities, are among the reasons medical gases still hold the largest share of the overall medical gas and equipment market.

“By application, the therapeutic applications  segment is expected to have the largest market share in the medical gas and equipment market.”

Therapeutic uses account for the largest share of the application segment in the medical gas and equipment market, as medical gases are of prime importance to the treatment and management of various acute and chronic conditions. Oxygen, nitrous oxide, and medical air are used in almost all cases of respiratory therapy, critical care, emergency medicine, anesthesia, and pain management, making them essential equipment in hospitals, clinics, and home care. With the rise in the number of people suffering from chronic respiratory and cardiovascular diseases, along with the increase in the elderly population, there has been a consequent demand for long-term, continuous therapeutic gas administration. In addition, more hospital admissions, higher surgical volumes, and the expanded use of home healthcare and long-term oxygen therapy further support the prominence of therapeutic applications. Consequently, the continuous, large-scale use of medical gases for patient treatment continues to drive the leading share of this segment in the medical gas and equipment market.

“The US is expected to grow at the highest CAGR for the North America medical gas and equipment market.”

The US market for medical gases and equipment is projected to have the highest CAGR in North America, driven by advanced healthcare infrastructure and high healthcare spending. Rising chronic respiratory and cardiovascular illnesses and an aging population are major factors behind substantial demand for medical gases such as oxygen and their delivery equipment. In addition, increased hospitalizations, growth in ICU facilities, and rising surgical volumes are accelerating the installation and upgrades of medical gas pipeline systems and equipment. The boom in home healthcare and the long-term oxygen therapy market, along with stringent patient safety regulations and compliance requirements, are propelling the market to grow faster. On top of that, ongoing technological progress and the presence of prominent medical gas manufacturers and service providers in the U.S. are helping the country maintain its position as the fastest-growing market in North America.

A breakdown of the primary participants (supply-side) for the medical gas and equipment market referred to for this report is provided below:

• By Company Type: Tier 1–35%, Tier 2–40%, and Tier 3–25%
• By Designation: C-level–45%, Director Level–35%, and Others–20%
• By Region: North America–27%, Europe–25%, Asia Pacific–30%, Latin America- 8%, Middle East & Africa-10% .

Prominent players in the medical gas and equipment market are Air Liquide (France), Linde Plc (Germany), Taiyo Nippon Sanso Corporation (Japan), Air Products and Chemicals Inc. (US), Atlas Copco AB (Sweden), GCE Group (Sweden), Messer SE & Co. KGaA (Germany), SOL Spa (Italy), Rotarex (Europe), Norco Inc. (US), Genstar Technologies (US), Southern Gas Limited (India), Calox Inc. (US), Ellenbarrie Industrial Gases (India), Steelman Gases Pvt. Ltd. (India), Butler Gas Products Company (US), SCI Analytical (US), Amico Group of Companies (US), Oxygen & Argon Works Ltd. (Israel), AOPL (India), Apex Medical Gas Inc. (US).

Research Coverage:

The report analyzes the medical gas and equipment market and aims to estimate the market size and future growth potential across various segments, including type, application, end user, and region. The report also includes a competitive analysis of the key players in this market, along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will provide market leaders and new entrants in this market with the closest available estimates of revenue for the overall medical gas and equipment market. It will help stakeholders understand the competitive landscape and gain insights to position their businesses more effectively and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

Analysis of key drivers (rising demand for medical oxygen, increasing number of surgeries, growing elderly population, and rising demand for home healthcare), restraints (declining reimbursements for respiratory therapies, and global helium shortage), opportunities (expansion of healthcare industry, rising demand for pain management, and advancements in healthcare technology) and challenges (limited availability of medical gases, and high cost of medical gas equipment).

• Market Penetration: It includes extensive information on products offered by the major players in the global the medical gas and equipment market. The report includes various segments in type, application, end user and region.
• Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global medical gas and equipment market.
• Market Development: Thorough knowledge and analysis of the profitable rising markets by offering, application, end user and region.
• Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global the medical gas and equipment market.
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global medical gas and equipment market.

Table of Contents

1 INTRODUCTION 35
1.1 STUDY OBJECTIVES 35
1.2 MARKET DEFINITION 35
1.3 STUDY SCOPE 36
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 36
1.3.2 INCLUSIONS & EXCLUSIONS 37
1.3.3 YEARS CONSIDERED 37
1.3.4 CURRENCY CONSIDERED 38
1.4 STAKEHOLDERS 38
1.5 SUMMARY OF CHANGES 38
2 EXECUTIVE SUMMARY 40
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS 40
2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS 45
2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH 46
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 47
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 48
3 PREMIUM INSIGHTS 49
3.1 MEDICAL GAS AND EQUIPMENT MARKET OVERVIEW 49
3.2 ASIA PACIFIC MEDICAL GAS AND EQUIPMENT MARKET 50
3.3 MEDICAL GAS AND EQUIPMENT MARKET: REGIONAL MIX 51
3.4 MEDICAL GAS AND EQUIPMENT MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 51
3.5 MEDICAL GAS AND EQUIPMENT MARKET: DEVELOPING VS. DEVELOPED MARKETS 52
4 MARKET OVERVIEW 53
4.1 INTRODUCTION 53
4.2 MARKET DYNAMICS 53
4.2.1 DRIVERS 54
4.2.1.1 Increasing demand for medical oxygen 54
4.2.1.2 Growing number of surgeries 54
4.2.1.3 Expansion of geriatric population and subsequent rise in chronic diseases 55
4.2.1.4 Shift toward home healthcare settings 55
4.2.2 RESTRAINTS 56
4.2.2.1 Declining reimbursements for respiratory therapies 56
4.2.2.2 Strict regulatory and safety compliance requirements 56
4.2.3 OPPORTUNITIES 57
4.2.3.1 Expansion of healthcare industry 57
4.2.3.2 Surge in demand for pain management solutions 57
4.2.3.3 Growing advancements in healthcare technologies 58
4.2.4 CHALLENGES 58
4.2.4.1 Limited availability of medical gases 58
4.2.4.2 High cost of medical gas equipment 59
4.3 UNMET NEEDS & WHITE SPACES 59
4.3.1 UNMET NEEDS IN MEDICAL GAS AND EQUIPMENT MARKET 59
4.3.2 WHITE SPACE OPPORTUNITIES 60
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 61
4.4.1 INTERCONNECTED MARKETS 61
4.4.2 CROSS-SECTOR OPPORTUNITIES 62
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 63
5 INDUSTRY TRENDS 65
5.1 PORTER’S FIVE FORCES ANALYSIS 65
5.1.1 THREAT OF NEW ENTRANTS 66
5.1.2 THREAT OF SUBSTITUTES 66
5.1.3 BARGAINING POWER OF SUPPLIERS 66
5.1.4 BARGAINING POWER OF BUYERS 66
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 66
5.2 MACROECONOMIC OUTLOOK 66
5.2.1 INTRODUCTION 66
5.2.2 GDP TRENDS & FORECAST 67
5.2.3 TRENDS IN RESPIRATORY CARE DEVICES INDUSTRY 68
5.2.4 TRENDS IN MEDICAL NITROUS OXIDE INDUSTRY 69
5.3 SUPPLY CHAIN ANALYSIS 69
5.4 VALUE CHAIN ANALYSIS 70
5.5 ECOSYSTEM ANALYSIS 71
5.6 PRICING ANALYSIS 72
5.6.1 AVERAGE SELLING PRICE TREND OF MEDICAL GASES, BY KEY PLAYER (2023–2025) 72
5.6.2 AVERAGE SELLING PRICE TREND OF MEDICAL GASES AND EQUIPMENT,
BY REGION (2023–2025) 73
5.7 TRADE DATA ANALYSIS 74
5.7.1 IMPORT DATA 74
5.7.2 EXPORT DATA 75
5.8 KEY CONFERENCES & EVENTS, 2026–2027 75
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 76
5.10 INVESTMENT & FUNDING SCENARIO 77
5.11 CASE STUDY ANALYSIS 77
5.11.1 CASE STUDY 1: ADOPTION OF COMPUTERIZED TRACKING SYSTEM FOR IMPROVED PATIENT SAFETY AND STREAMLINED COMPLIANCE DOCUMENTATION 77
5.11.2 CASE STUDY 2: IMPLEMENTATION OF COMPREHENSIVE ALARM MANAGEMENT SYSTEM FOR RESPONSIBLE SURVEILLANCE 78
5.11.3 CASE STUDY 3: DEVELOPMENT OF PRESSURE SWING ADSORPTION PLANTS TO MEET INCREASING NEEDS OF LIQUID MEDICAL OXYGEN 78
5.12 IMPACT OF 2025 US TARIFFS ON MEDICAL GAS AND EQUIPMENT MARKET 79
5.12.1 INTRODUCTION 79
5.12.2 KEY TARIFF RATES 79
5.12.3 PRICE IMPACT ANALYSIS 80
5.12.4 IMPACT ON COUNTRY/REGION 81
5.12.4.1 US 81
5.12.4.2 Europe 81
5.12.4.3 Asia Pacific 81
5.12.4.4 Latin America 81
5.12.4.5 Middle East & Africa/GCC 81
5.12.5 IMPACT ON END USER INDUSTRIES 82
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 83
6.1 KEY EMERGING TECHNOLOGIES 83
6.1.1 SMART MEDICAL GAS MONITORING SYSTEMS 83
6.1.2 AI-BASED PREDICTIVE MAINTENANCE 83
6.1.3 DIGITAL TWIN TECHNOLOGY 83
6.2 COMPLEMENTARY TECHNOLOGIES 84
6.2.1 MEDICAL GAS PIPELINE SYSTEMS (MGPS) 84
6.3 ADJACENT TECHNOLOGIES 84
6.3.1 HEALTHCARE IOT (IOMT) 84
6.4 TECHNOLOGY/PRODUCT ROADMAP 85
6.4.1 SHORT TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION 85
6.4.2 MID TERM (2027–2030) | EXPANSION & STANDARDIZATION 86
6.4.3 LONG TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION 87
6.5 PATENT ANALYSIS 89
6.6 FUTURE APPLICATIONS OF MEDICAL GAS AND EQUIPMENT 90
6.7 IMPACT OF AI/GEN AI ON MEDICAL GAS AND EQUIPMENT MARKET 92
6.7.1 TOP USE CASES & MARKET POTENTIAL 92
6.7.2 BEST PRACTICES IN MEDICAL GAS AND EQUIPMENT PROCESSING 93
6.7.3 CASE STUDIES OF AI IMPLEMENTATION IN MEDICAL GAS AND EQUIPMENT MARKET 93
6.7.4 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS 94
6.7.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN MEDICAL GAS AND EQUIPMENT MARKET 95
7 REGULATORY LANDSCAPE 97
7.1 REGIONAL REGULATIONS & COMPLIANCE 97
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97
7.1.2 INDUSTRY STANDARDS 101
7.2 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 102
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 103
8.1 DECISION-MAKING PROCESS 103
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA 104
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 104
8.2.2 BUYING CRITERIA 105
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 105
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 106
8.5 MARKET PROFITABILITY 107
8.5.1 REVENUE POTENTIAL 107
8.5.2 COST DYNAMICS 107
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 108
9 MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE 109
9.1 INTRODUCTION 110
9.2 MEDICAL GASES 110
9.2.1 PURE MEDICAL GASES 111
9.2.1.1 Oxygen 113
9.2.1.1.1 Increasing prevalence of respiratory diseases to accelerate growth 113
9.2.1.2 Carbon dioxide 115
9.2.1.2.1 Evolving technologies and treatment methods in healthcare sector to facilitate growth 115
9.2.1.3 Nitrogen 116
9.2.1.3.1 Growing utilization in reproductive medicine and regenerative medicine to drive market 116
9.2.1.4 Nitrous oxide 118
9.2.1.4.1 Increasing emphasis on patient comfort to contribute to market growth 118
9.2.1.5 Medical air 120
9.2.1.5.1 Growing need for advanced healthcare infrastructure to boost market 120
9.2.1.6 Other pure medical gases 122
9.2.2 MEDICAL GAS MIXTURES 124
9.2.2.1 Blood gas mixtures 126
9.2.2.1.1 Growing integration with electronic health records and other diagnostic systems to boost market 126
9.2.2.2 Lung diffusion mixtures 127
9.2.2.2.1 Rising importance of early detection and management of lung disorders to favor growth 127
9.2.2.3 Nitrous oxide-oxygen mixtures 128
9.2.2.3.1 Expanding role in anesthesia and pain management to sustain growth 128
9.2.2.4 Carbon dioxide-oxygen mixtures 130
9.2.2.4.1 Growing adoption of minimally invasive surgical techniques to propel market 130
9.2.2.5 Laser gas mixtures 131
9.2.2.5.1 Increasing applications in dermatology, ophthalmology, and oncology to stimulate growth 131
9.2.2.6 Anaerobic gas mixtures 132
9.2.2.6.1 Increasing adoption of advanced equipment in clinical and research settings to promote growth 132
9.2.2.7 Aerobic gas mixtures 133
9.2.2.7.1 Booming geriatric population and rising pollution levels to drive market 133
9.2.2.8 Helium-oxygen mixtures 134
9.2.2.8.1 Rising benefits in emergency and routine medical care to expedite growth 134
9.2.2.9 Other medical gas mixtures 136
9.3 MEDICAL GAS EQUIPMENT 137
9.3.1 GAS DELIVERY SYSTEMS 138
9.3.1.1 Rising focus on patient stability and recovery to promote growth 138
9.3.2 GAS SUPPLY EQUIPMENT 140
9.3.2.1 Medical gas cylinders 141
9.3.2.1.1 Growing demand for portable oxygen delivery and emergency medical preparedness to propel market 141
9.3.2.2 Bulk storage systems 143
9.3.2.2.1 Rising healthcare infrastructure expansion and increasing medical gas consumption to propel market 143
9.3.2.3 Liquid oxygen systems 144
9.3.2.3.1 Increasing demand for high-volume oxygen supply and critical care services to propel market 144
9.3.2.4 Cryogenic tanks 145
9.3.2.4.1 Growing adoption of centralized medical gas storage and rising demand for large-capacity gas reserves to propel market 145
9.3.2.5 Vacuum systems 146
9.3.2.5.1 Growing focus on infection control and complex surgical therapies to propel market 146
9.3.2.6 Medical air compressors 148
9.3.2.6.1 Increasing demand for advanced healthcare services to augment growth 148
9.3.3 GAS REGULATION & MONITORING EQUIPMENT 149
9.3.3.1 Regulators 151
9.3.3.1.1 Rising focus on treatment efficacy and patient safety to augment growth 151
9.3.3.2 Flowmeters 152
9.3.3.2.1 Increasing use in anesthesia, respiratory therapy, and neonatal care applications to boost market 152
9.3.3.3 Valves with integrated pressure regulators (VIPRs) 153
9.3.3.3.1 Rising focus on improved patient care and streamlined operations to favor growth 153
9.3.3.4 Pressure gauges 154
9.3.3.4.1 Increasing emphasis on medical gas safety and real-time pressure monitoring to propel market 154
9.3.3.5 Gas monitoring systems 155
9.3.3.5.1 Need for safe and effective delivery of medical gases to aid growth 155
9.3.4 OTHER EQUIPMENT & ACCESSORIES 157
10 MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION 159
10.1 INTRODUCTION 160
10.2 THERAPEUTIC APPLICATIONS 160
10.2.1 RESPIRATORY THERAPIES 162
10.2.1.1 Increasing accessibility of portable and home-based respiratory therapy equipment to boost market 162
10.2.2 CARDIOVASCULAR THERAPIES 163
10.2.2.1 Sedentary lifestyles and poor dietary habits to sustain growth 163
10.2.3 ANESTHESIA DELIVERY 165
10.2.3.1 Growing incidence of age-related health conditions to fuel market 165
10.2.4 CRYOSURGERY APPLICATIONS 166
10.2.4.1 Increasing demand for minimally invasive and cost-effective treatments to promote growth 166
10.2.5 OTHER THERAPEUTIC APPLICATIONS 167
10.3 PHARMACEUTICAL MANUFACTURING & RESEARCH APPLICATIONS 168
10.3.1 BOOMING BIOPHARMACEUTICAL RESEARCH & DEVELOPMENT INITIATIVES TO ENCOURAGE GROWTH 168
10.4 DIAGNOSTIC APPLICATIONS 169
10.4.1 MEDICAL IMAGING 171
10.4.1.1 Rising demand for high-resolution imaging and advanced diagnostic capabilities to propel market 171
10.4.2 GENERAL LABORATORY APPLICATIONS 172
10.4.2.1 Need for efficient functioning of equipment and compliance with regulatory standards to drive market 172
10.5 OTHER APPLICATIONS 174
11 MEDICAL GAS AND EQUIPMENT MARKET, BY END USER 176
11.1 INTRODUCTION 177
11.2 HOSPITALS & CLINICS 177
11.2.1 BOOMING OUTPATIENT CARE AND SPECIALIZED CLINIC SERVICES TO AUGMENT GROWTH 177
11.3 HOME HEALTHCARE 179
11.3.1 GROWING SHIFT TOWARD HOME HEALTHCARE TO SUPPORT MARKET 179
11.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 180
11.4.1 ONGOING ADVANCEMENTS IN PERSONALIZED MEDICINE, GENE THERAPY, AND IMMUNOTHERAPY TO ENCOURAGE GROWTH 180
11.5 ACADEMIC & RESEARCH INSTITUTIONS 181
11.5.1 GROWING IMPORTANCE OF HIGH-QUALITY EDUCATION AND TRAINING TO BOOST MARKET 181
11.6 OTHER END USERS 182
12 MEDICAL GAS AND EQUIPMENT MARKET, BY REGION 184
12.1 INTRODUCTION 185
12.2 NORTH AMERICA 185
12.2.1 US 191
12.2.1.1 Presence of key players to sustain growth 191
12.2.2 CANADA 196
12.2.2.1 Stringent regulatory compliance to favor market growth 196
12.3 EUROPE 202
12.3.1 GERMANY 208
12.3.1.1 Growing adoption of advanced healthcare technologies to fuel market 208
12.3.2 UK 213
12.3.2.1 Growing aging population to drive market 213
12.3.3 FRANCE 218
12.3.3.1 Well-established healthcare system to support growth 218
12.3.4 SPAIN 223
12.3.4.1 High burden of chronic diseases to augment growth 223
12.3.5 ITALY 228
12.3.5.1 Rising demand for therapeutic gases to aid growth 228
12.3.6 REST OF EUROPE 233
12.4 ASIA PACIFIC 239
12.4.1 JAPAN 245
12.4.1.1 Dominant elderly population to propel market 245
12.4.2 CHINA 250
12.4.2.1 Strong public healthcare infrastructure to stimulate growth 250
12.4.3 INDIA 255
12.4.3.1 Growing incidence of cardiovascular diseases to spur growth 255
12.4.4 AUSTRALIA 260
12.4.4.1 Robust Medicare program to facilitate growth 260
12.4.5 SOUTH KOREA 265
12.4.5.1 Increasing cases of heart disease, obesity, cancer, and diabetes to drive market 265
12.4.6 REST OF ASIA PACIFIC 270
12.5 LATIN AMERICA 275
12.5.1 BRAZIL 281
12.5.1.1 Increasing healthcare spending to contribute to market growth 281
12.5.2 MEXICO 286
12.5.2.1 Expanding pharmaceutical industry to propel market 286
12.5.3 REST OF LATIN AMERICA 291
12.6 MIDDLE EAST & AFRICA 296
12.6.1 FAVORABLE GOVERNMENT INITIATIVES FOR INFRASTRUCTURE DEVELOPMENT TO DRIVE MARKET 296
12.6.2 GCC COUNTRIES 302
12.6.2.1 Increasing prevalence of cardiovascular diseases to augment growth 302
12.6.3 REST OF MIDDLE EAST & AFRICA 307
13 COMPETITIVE LANDSCAPE 313
13.1 INTRODUCTION 313
13.2 KEY PLAYER STRATEGY/RIGHT TO WIN 313
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL GAS AND EQUIPMENT MARKET 313
13.3 REVENUE ANALYSIS, 2021–2025 315
13.4 MARKET SHARE ANALYSIS, 2025 316
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 318
13.5.1 STARS 318
13.5.2 EMERGING LEADERS 318
13.5.3 PERVASIVE PLAYERS 318
13.5.4 PARTICIPANTS 319
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 320
13.5.5.1 Company footprint 320
13.5.5.2 Region footprint 321
13.5.5.3 Type footprint 322
13.5.5.4 Application footprint 323
13.5.5.5 End-user footprint 324
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 326
13.6.1 PROGRESSIVE COMPANIES 326
13.6.2 RESPONSIVE COMPANIES 326
13.6.3 DYNAMIC COMPANIES 326
13.6.4 STARTING BLOCKS 326
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 328
13.6.5.1 Detailed list of key startups/SMEs 328
13.6.5.2 Competitive benchmarking of startups/SMEs 329
13.7 BRAND/PRODUCT COMPARISON 330
13.8 COMPANY VALUATION & FINANCIAL METRICS 331
13.8.1 FINANCIAL METRICS 331
13.8.2 COMPANY VALUATION 331
13.9 COMPETITIVE SCENARIO 332
13.9.1 DEALS 332
13.9.2 EXPANSIONS 333
13.9.3 THER DEVELOPMENTS 333
14 COMPANY PROFILES 334
14.1 KEY PLAYERS 334
14.1.1 LINDE PLC 334
14.1.1.1 Business overview 334
14.1.1.2 Products offered 335
14.1.1.3 Recent developments 336
14.1.1.3.1 Expansions 336
14.1.1.4 MnM view 337
14.1.1.4.1 Right to win 337
14.1.1.4.2 Strategic choices 337
14.1.1.4.3 Weaknesses & competitive threats 337
14.1.2 AIR LIQUIDE 338
14.1.2.1 Business overview 338
14.1.2.2 Products offered 339
14.1.2.3 Recent developments 341
14.1.2.3.1 Deals 341
14.1.2.3.2 Expansions 341
14.1.2.3.3 Other developments 342
14.1.2.4 MnM view 342
14.1.2.4.1 Right to win 342
14.1.2.4.2 Strategic choices 342
14.1.2.4.3 Weaknesses & competitive threats 342
14.1.3 MESSER SE & CO. KGAA 343
14.1.3.1 Business overview 343
14.1.3.2 Products offered 344
14.1.3.3 Recent developments 345
14.1.3.3.1 Deals 345
14.1.3.3.2 Expansions 345
14.1.3.4 MnM view 346
14.1.3.4.1 Right to win 346
14.1.3.4.2 Strategic choices 346
14.1.3.4.3 Weaknesses & competitive threats 346
14.1.4 AIR PRODUCTS AND CHEMICALS, INC. 347
14.1.4.1 Business overview 347
14.1.4.2 Products offered 348
14.1.4.3 MnM view 349
14.1.4.3.1 Right to win 349
14.1.4.3.2 Strategic choices 349
14.1.4.3.3 Weaknesses & competitive threats 349
14.1.5 NIPPON SANSO HOLDINGS CORPORATION 350
14.1.5.1 Business overview 350
14.1.5.2 Products offered 351
14.1.5.3 Recent developments 352
14.1.5.3.1 Deals 352
14.1.5.4 MnM view 352
14.1.5.4.1 Right to win 352
14.1.5.4.2 Strategic choices 352
14.1.5.4.3 Weaknesses & competitive threats 352
14.1.6 ATLAS COPCO AB 353
14.1.6.1 Business overview 353
14.1.6.2 Products offered 354
14.1.6.3 Recent developments 355
14.1.6.3.1 Deals 355
14.1.7 GCE GROUP 357
14.1.7.1 Business overview 357
14.1.7.2 Products offered 357
14.1.7.3 Recent developments 359
14.1.7.3.1 Deals 359
14.1.8 SOL SPA 360
14.1.8.1 Business overview 360
14.1.8.2 Products offered 361
14.1.8.3 Recent developments 362
14.1.8.3.1 Deals 362
14.1.8.3.2 Expansions 363
14.1.9 ROTAREX 364
14.1.9.1 Business overview 364
14.1.9.2 Products offered 364
14.1.10 NORCO INC. 367
14.1.10.1 Business overview 367
14.1.10.2 Products offered 367
14.1.11 GENSTAR TECHNOLOGIES 368
14.1.11.1 Business overview 368
14.1.11.2 Products offered 368
14.1.12 SOUTHERN GAS LIMITED 371
14.1.12.1 Business overview 371
14.1.12.2 Products offered 372
14.1.13 DRÄGERWERK AG & CO. KGAA 373
14.1.13.1 Business overview 373
14.1.13.2 Products offered 375
14.1.14 CALOX INC. 376
14.1.14.1 Business overview 376
14.1.14.2 Products offered 376
14.1.15 PT SAMATOR INDO GAS TBK 377
14.1.15.1 Business overview 377
14.1.15.2 Products offered 378
14.2 OTHER PLAYERS 380
14.2.1 BUTLER GAS PRODUCTS COMPANY 380
14.2.2 AMICO GROUP OF COMPANIES 381
14.2.3 AIMS OXYGEN PVT LTD. (AOPL) 382
14.2.4 APEX MEDICAL GAS INC. 383
14.2.5 CHENGDU TAIYO INDUSTRIAL GASES CO., LTD. 384
14.2.6 STEELMAN GASES PVT. LTD. 385
14.2.7 CARBIDE AND CHEMICALS 386
14.2.8 HOLSTON GASES 387
14.2.9 MEC MEDICAL LTD. 388
14.2.10 PRECISION UK 389
15 RESEARCH METHODOLOGY 390
15.1 RESEARCH DATA 390
15.1.1 SECONDARY DATA 391
15.1.1.1 Key data from secondary sources 391
15.1.2 PRIMARY DATA 392
15.1.2.1 Key data from primary sources 393
15.1.2.2 Key industry insights 393
15.2 MARKET SIZE ESTIMATION 393
15.2.1 BOTTOM-UP APPROACH 394
15.2.2 TOP-DOWN APPROACH 394
15.2.3 BASE NUMBER ESTIMATION 395
15.3 MARKET FORECAST APPROACH 397
15.4 MARKET BREAKDOWN & DATA TRIANGULATION 399
15.5 ASSUMPTIONS 400
15.5.1 MARKET SHARE ASSUMPTIONS 400
15.5.2 RESEARCH ASSUMPTIONS 400
15.6 FACTOR ANALYSIS 401
15.7 RISK ASSESSMENT 401
15.8 METHODOLOGY-RELATED LIMITATIONS 402
16 APPENDIX 403
16.1 DISCUSSION GUIDE 403
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 410
16.3 CUSTOMIZATION OPTIONS 412
16.4 RELATED REPORTS 412
16.5 AUTHOR DETAILS 413

LIST OF TABLES

TABLE 1 MEDICAL GAS AND EQUIPMENT MARKET: INCLUSIONS & EXCLUSIONS 37
TABLE 2 MEDICAL GAS AND EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 65
TABLE 3 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021–2030 67
TABLE 4 AVERAGE SELLING PRICE TREND OF MEDICAL GASES, BY KEY PLAYER,
2023–2025 (USD MILLION) 72
TABLE 5 AVERAGE SELLING PRICE OF OXYGEN, BY REGION, 2023–2025 (USD) 73
TABLE 6 AVERAGE SELLING PRICE OF NITROUS OXIDE, BY REGION, 2023–2025 (USD) 73
TABLE 7 AVERAGE SELLING PRICE OF PORTABLE OXYGEN CONCENTRATORS, BY REGION, 2023–2025 (USD) 74
TABLE 8 AVERAGE SELLING PRICE OF REGULATORS, BY REGION, 2023–2025 (USD) 74
TABLE 9 IMPORT DATA OF MEDICAL GAS AND EQUIPMENT FOR HS CODE 2804,
BY COUNTRY, 2021–2025 (USD THOUSAND) 74
TABLE 10 EXPORT DATA OF MEDICAL GAS AND EQUIPMENT FOR HS CODE 2804,
BY COUNTRY, 2021–2025 (USD THOUSAND) 75
TABLE 11 MEDICAL GAS AND EQUIPMENT MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS (2026–2027) 75
TABLE 12 US-ADJUSTED RECIPROCAL TARIFF RATES 79
TABLE 13 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR MEDICAL GAS AND EQUIPMENT 80
TABLE 14 MEDICAL GAS AND EQUIPMENT MARKET: CASE STUDIES RELATED TO AI IMPLEMENTATION 93
TABLE 15 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS 94
TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97
TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98
TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 99
TABLE 19 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100
TABLE 20 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100
TABLE 21 GLOBAL STANDARDS IN MEDICAL GAS AND EQUIPMENT MARKET 101
TABLE 22 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN MEDICAL GAS AND EQUIPMENT MARKET 102
TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL GAS AND EQUIPMENT, BY TYPE 104
TABLE 24 KEY BUYING CRITERIA FOR MEDICAL GAS AND EQUIPMENT, BY TYPE 105
TABLE 25 MEDICAL GAS AND EQUIPMENT MARKET: UNMET NEEDS/
END-USER EXPECTATIONS 106
TABLE 26 MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 110
TABLE 27 MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 110
TABLE 28 MEDICAL GASES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 111
TABLE 29 PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 112
TABLE 30 PURE MEDICAL GASES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 112
TABLE 31 PURE MEDICAL GASES MARKET FOR OXYGEN, BY COUNTRY,
2024–2031 (USD MILLION) 113
TABLE 32 MEDICAL GAS AND EQUIPMENT SYSTEMS MARKET FOR OXYGEN, BY REGION, 2024–2031 (MILLION CUBIC METERS) 114
TABLE 33 PURE MEDICAL GASES MARKET FOR CARBON DIOXIDE, BY COUNTRY,
2024–2031 (USD MILLION) 115
TABLE 34 MEDICAL GAS AND EQUIPMENT SYSTEMS MARKET FOR CARBON DIOXIDE,
BY REGION, 2024–2031 (MILLION CUBIC METERS) 116
TABLE 35 PURE MEDICAL GASES MARKET FOR NITROGEN, BY COUNTRY,
2024–2031 (USD MILLION) 117
TABLE 36 MEDICAL GAS AND EQUIPMENT SYSTEMS MARKET FOR NITROGEN, BY REGION, 2024–2031 (MILLION CUBIC METERS) 118
TABLE 37 PURE MEDICAL GASES MARKET FOR NITROUS OXIDE, BY COUNTRY,
2024–2031 (USD MILLION) 119
TABLE 38 MEDICAL GAS AND EQUIPMENT SYSTEMS MARKET FOR NITROUS OXIDE,
BY REGION, 2024–2031 (MILLION CUBIC METERS) 120
TABLE 39 PURE MEDICAL GASES MARKET FOR MEDICAL AIR, BY COUNTRY,
2024–2031 (USD MILLION) 121
TABLE 40 MEDICAL GAS AND EQUIPMENT SYSTEMS MARKET FOR MEDICAL AIR, BY REGION, 2024–2031 (MILLION CUBIC METERS) 122
TABLE 41 OTHER PURE MEDICAL GASES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 123
TABLE 42 MEDICAL GAS AND EQUIPMENT SYSTEMS MARKET FOR OTHER PURE MEDICAL GASES, BY REGION, 2024–2031 (MILLION CUBIC METERS) 124
TABLE 43 MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION) 125
TABLE 44 MEDICAL GAS MIXTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 125
TABLE 45 MEDICAL GAS MIXTURES MARKET FOR BLOOD GAS MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION) 126
TABLE 46 MEDICAL GAS MIXTURES MARKET FOR LUNG DIFFUSION MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION) 128
TABLE 47 MEDICAL GAS MIXTURES MARKET FOR NITROUS OXIDE-OXYGEN MIXTURES,
BY COUNTRY, 2024–2031 (USD MILLION) 129
TABLE 48 MEDICAL GAS MIXTURES MARKET FOR CARBON DIOXIDE-OXYGEN MIXTURES,
BY COUNTRY, 2024–2031 (USD MILLION) 130
TABLE 49 MEDICAL GAS MIXTURES MARKET FOR LASER GAS MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION) 131
TABLE 50 MEDICAL GAS MIXTURES MARKET FOR ANAEROBIC GAS MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION) 132
TABLE 51 MEDICAL GAS MIXTURES MARKET FOR AEROBIC GAS MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION) 134
TABLE 52 MEDICAL GAS MIXTURES MARKET FOR HELIUM-OXYGEN MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION) 135
TABLE 53 OTHER MEDICAL GAS MIXTURES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 136
TABLE 54 MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 137
TABLE 55 MEDICAL GAS EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 138
TABLE 56 GAS DELIVERY SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 139
TABLE 57 GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 140
TABLE 58 GAS SUPPLY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 141
TABLE 59 GAS SUPPLY EQUIPMENT MARKET FOR MEDICAL GAS CYLINDERS, BY COUNTRY, 2024–2031 (USD MILLION) 142
TABLE 60 GAS SUPPLY EQUIPMENT MARKET FOR BULK STORAGE SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 143
TABLE 61 GAS SUPPLY EQUIPMENT MARKET FOR LIQUID OXYGEN SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 144
TABLE 62 GAS SUPPLY EQUIPMENT MARKET FOR CRYOGENIC TANKS, BY COUNTRY,
2024–2031 (USD MILLION) 146
TABLE 63 GAS SUPPLY EQUIPMENT MARKET FOR VACUUM SYSTEMS, BY COUNTRY,
2024–2031 (USD MILLION) 147
TABLE 64 GAS SUPPLY EQUIPMENT MARKET FOR MEDICAL AIR COMPRESSORS,
BY COUNTRY, 2024–2031 (USD MILLION) 148
TABLE 65 GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 149
TABLE 66 GAS REGULATION & MONITORING EQUIPMENT MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 150
TABLE 67 GAS REGULATION & MONITORING EQUIPMENT MARKET FOR REGULATORS,
BY COUNTRY, 2024–2031 (USD MILLION) 151
TABLE 68 GAS REGULATION & MONITORING EQUIPMENT MARKET FOR FLOWMETERS,
BY COUNTRY, 2024–2031 (USD MILLION) 152
TABLE 69 GAS REGULATION & MONITORING EQUIPMENT MARKET FOR VALVES WITH INTEGRATED PRESSURE REGULATORS (VIPRS), BY COUNTRY,
2024–2031 (USD MILLION) 153
TABLE 70 GAS REGULATION & MONITORING EQUIPMENT MARKET FOR PRESSURE GAUGES, BY COUNTRY, 2024–2031 (USD MILLION) 155
TABLE 71 GAS REGULATION & MONITORING EQUIPMENT MARKET FOR GAS MONITORING SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 156
TABLE 72 OTHER EQUIPMENT & ACCESSORIES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 158
TABLE 73 MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 160
TABLE 74 MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS,
BY TYPE, 2024–2031 (USD MILLION) 161
TABLE 75 MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS,
BY COUNTRY, 2024–2031 (USD MILLION) 161
TABLE 76 MEDICAL GAS AND EQUIPMENT MARKET FOR RESPIRATORY THERAPIES,
BY COUNTRY, 2024–2031 (USD MILLION) 162
TABLE 77 MEDICAL GAS AND EQUIPMENT MARKET FOR CARDIOVASCULAR THERAPIES,
BY COUNTRY, 2024–2031 (USD MILLION) 164
TABLE 78 MEDICAL GAS AND EQUIPMENT MARKET FOR ANESTHESIA DELIVERY,
BY COUNTRY, 2024–2031 (USD MILLION) 165
TABLE 79 MEDICAL GAS AND EQUIPMENT MARKET FOR CRYOSURGERY APPLICATIONS,
BY COUNTRY, 2024–2031 (USD MILLION) 166
TABLE 80 MEDICAL GAS AND EQUIPMENT MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 167
TABLE 81 MEDICAL GAS AND EQUIPMENT MARKET FOR PHARMACEUTICAL MANUFACTURING & RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 169
TABLE 82 MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS,
BY TYPE, 2024–2031 (USD MILLION) 170
TABLE 83 MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS,
BY COUNTRY, 2024–2031 (USD MILLION) 170
TABLE 84 MEDICAL GAS AND EQUIPMENT MARKET FOR MEDICAL IMAGING, BY COUNTRY, 2024–2031 (USD MILLION) 171
TABLE 85 MEDICAL GAS AND EQUIPMENT MARKET FOR GENERAL LABORATORY APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 173
TABLE 86 MEDICAL GAS AND EQUIPMENT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 174
TABLE 87 MEDICAL GAS AND EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 177
TABLE 88 MEDICAL GAS AND EQUIPMENT MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION) 178
TABLE 89 MEDICAL GAS AND EQUIPMENT MARKET FOR HOME HEALTHCARE, BY COUNTRY, 2024–2031 (USD MILLION) 179
TABLE 90 MEDICAL GAS AND EQUIPMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 180
TABLE 91 MEDICAL GAS AND EQUIPMENT MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2024–2031 (USD MILLION) 182
TABLE 92 MEDICAL GAS AND EQUIPMENT MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 183
TABLE 93 MEDICAL GAS AND EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 185
TABLE 94 NORTH AMERICA: MEDICAL GAS AND EQUIPMENT MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 186
TABLE 95 NORTH AMERICA: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 187
TABLE 96 NORTH AMERICA: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 187
TABLE 97 NORTH AMERICA: PURE MEDICAL GASES MARKET, BY TYPE,
2024–2031 (USD MILLION) 187
TABLE 98 NORTH AMERICA: MEDICAL GAS MIXTURES MARKET, BY TYPE,
2024–2031 (USD MILLION) 188
TABLE 99 NORTH AMERICA: MEDICAL GAS EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 188
TABLE 100 NORTH AMERICA: GAS SUPPLY EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 189
TABLE 101 NORTH AMERICA: GAS REGULATION & MONITORING EQUIPMENT MARKET,
BY TYPE, 2024–2031 (USD MILLION) 189
TABLE 102 NORTH AMERICA: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 190
TABLE 103 NORTH AMERICA: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 190
TABLE 104 NORTH AMERICA: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 191
TABLE 105 NORTH AMERICA: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 191
TABLE 106 US: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 192
TABLE 107 US: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 192
TABLE 108 US: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 192
TABLE 109 US: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION) 193
TABLE 110 US: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 193
TABLE 111 US: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 194
TABLE 112 US: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 194
TABLE 113 US: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 195
TABLE 114 US: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS,
BY TYPE, 2024–2031 (USD MILLION) 195
TABLE 115 US: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS,
BY TYPE, 2024–2031 (USD MILLION) 196
TABLE 116 US: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 196
TABLE 117 CANADA: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 197
TABLE 118 CANADA: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 197
TABLE 119 CANADA: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 198
TABLE 120 CANADA: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION) 198
TABLE 121 CANADA: MEDICAL GAS EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 199
TABLE 122 CANADA: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 199
TABLE 123 CANADA: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 200
TABLE 124 CANADA: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 200
TABLE 125 CANADA: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 201
TABLE 126 CANADA: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 201
TABLE 127 CANADA: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 202
TABLE 128 EUROPE: MEDICAL GAS AND EQUIPMENT MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 203
TABLE 129 EUROPE: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 203
TABLE 130 EUROPE: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 203
TABLE 131 EUROPE: MARKET FOR PURE MEDICAL GASES, BY TYPE,
2024–2031 (USD MILLION) 204
TABLE 132 EUROPE: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION) 204
TABLE 133 EUROPE: MEDICAL GAS EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 205
TABLE 134 EUROPE: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 205
TABLE 135 EUROPE: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 206
TABLE 136 EUROPE: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 206
TABLE 137 EUROPE: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 207
TABLE 138 EUROPE: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 207
TABLE 139 EUROPE: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 208
TABLE 140 GERMANY: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 209
TABLE 141 GERMANY: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 209
TABLE 142 GERMANY: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 209
TABLE 143 GERMANY: MEDICAL GAS MIXTURES MARKET, BY TYPE,
2024–2031 (USD MILLION) 210
TABLE 144 GERMANY: MEDICAL GAS EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 210
TABLE 145 GERMANY: GAS SUPPLY EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 211
TABLE 146 GERMANY: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 211
TABLE 147 GERMANY: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 212
TABLE 148 GERMANY: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 212
TABLE 149 GERMANY: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 213
TABLE 150 GERMANY: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 213
TABLE 151 UK: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 214
TABLE 152 UK: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 214
TABLE 153 UK: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 214
TABLE 154 UK: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION) 215
TABLE 155 UK: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 215
TABLE 156 UK: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 216
TABLE 157 UK: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 216
TABLE 158 UK: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 217
TABLE 159 UK: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS,
BY TYPE, 2024–2031 (USD MILLION) 217
TABLE 160 UK: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS,
BY TYPE, 2024–2031 (USD MILLION) 218
TABLE 161 UK: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 218
TABLE 162 FRANCE: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 219
TABLE 163 FRANCE: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 219
TABLE 164 FRANCE: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 219
TABLE 165 FRANCE: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION) 220
TABLE 166 FRANCE: MEDICAL GAS EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 220
TABLE 167 FRANCE: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 221
TABLE 168 FRANCE: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 221
TABLE 169 FRANCE: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 222
TABLE 170 FRANCE: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 222
TABLE 171 FRANCE: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 223
TABLE 172 FRANCE: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 223
TABLE 173 SPAIN: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 224
TABLE 174 SPAIN: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 224
TABLE 175 SPAIN: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 224
TABLE 176 SPAIN: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION) 225
TABLE 177 SPAIN: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 225
TABLE 178 SPAIN: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 226
TABLE 179 SPAIN: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 226
TABLE 180 SPAIN: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 227
TABLE 181 SPAIN: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 227
TABLE 182 SPAIN: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 228
TABLE 183 SPAIN: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 228
TABLE 184 ITALY: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 229
TABLE 185 ITALY: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 229
TABLE 186 ITALY: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 229
TABLE 187 ITALY: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION) 230
TABLE 188 ITALY: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 230
TABLE 189 ITALY: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 231
TABLE 190 ITALY: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 231
TABLE 191 ITALY: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 232
TABLE 192 ITALY: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 232
TABLE 193 ITALY: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 233
TABLE 194 ITALY: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 233
TABLE 195 REST OF EUROPE: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 234
TABLE 196 REST OF EUROPE: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 234
TABLE 197 REST OF EUROPE: PURE MEDICAL GASES MARKET, BY TYPE,
2024–2031 (USD MILLION) 234
TABLE 198 REST OF EUROPE: MEDICAL GAS MIXTURES MARKET, BY TYPE,
2024–2031 (USD MILLION) 235
TABLE 199 REST OF EUROPE: MEDICAL GAS EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 235
TABLE 200 REST OF EUROPE: GAS SUPPLY EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 236
TABLE 201 REST OF EUROPE: GAS REGULATION & MONITORING EQUIPMENT MARKET,
BY TYPE, 2024–2031 (USD MILLION) 236
TABLE 202 REST OF EUROPE: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 237
TABLE 203 REST OF EUROPE: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 237
TABLE 204 REST OF EUROPE: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 238
TABLE 205 REST OF EUROPE: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 238
TABLE 206 ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 240
TABLE 207 ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 240
TABLE 208 ASIA PACIFIC: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 240
TABLE 209 ASIA PACIFIC: PURE MEDICAL GASES MARKET, BY TYPE,
2024–2031 (USD MILLION) 241
TABLE 210 ASIA PACIFIC: MEDICAL GAS MIXTURES MARKET, BY TYPE,
2024–2031 (USD MILLION) 241
TABLE 211 ASIA PACIFIC: MEDICAL GAS EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 242
TABLE 212 ASIA PACIFIC: GAS SUPPLY EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 242
TABLE 213 ASIA PACIFIC: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 243
TABLE 214 ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 243
TABLE 215 ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 244
TABLE 216 ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 244
TABLE 217 ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 245
TABLE 218 JAPAN: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 245
TABLE 219 JAPAN: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 246
TABLE 220 JAPAN: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 246
TABLE 221 JAPAN: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION) 247
TABLE 222 JAPAN: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 247
TABLE 223 JAPAN: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 248
TABLE 224 JAPAN: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 248
TABLE 225 JAPAN: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 249
TABLE 226 JAPAN: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 249
TABLE 227 JAPAN: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 250
TABLE 228 JAPAN: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 250
TABLE 229 CHINA: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 251
TABLE 230 CHINA: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 251
TABLE 231 CHINA: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 251
TABLE 232 CHINA: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION) 252
TABLE 233 CHINA: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 252
TABLE 234 CHINA: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 253
TABLE 235 CHINA: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 253
TABLE 236 CHINA: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 254
TABLE 237 CHINA: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 254
TABLE 238 CHINA: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 255
TABLE 239 CHINA: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 255
TABLE 240 INDIA: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 256
TABLE 241 INDIA: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 256
TABLE 242 INDIA: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 256
TABLE 243 INDIA: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION) 257
TABLE 244 INDIA: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 257
TABLE 245 INDIA: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 258
TABLE 246 INDIA: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 258
TABLE 247 INDIA: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 259
TABLE 248 INDIA: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 259
TABLE 249 INDIA: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 260
TABLE 250 INDIA: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 260
TABLE 251 AUSTRALIA: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 261
TABLE 252 AUSTRALIA: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 261
TABLE 253 AUSTRALIA: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 261
TABLE 254 AUSTRALIA: MEDICAL GAS MIXTURES MARKET, BY TYPE,
2024–2031 (USD MILLION) 262
TABLE 255 AUSTRALIA: MEDICAL GAS EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 262
TABLE 256 AUSTRALIA: GAS SUPPLY EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 263
TABLE 257 AUSTRALIA: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 263
TABLE 258 AUSTRALIA: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 264
TABLE 259 AUSTRALIA: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 264
TABLE 260 AUSTRALIA: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 265
TABLE 261 AUSTRALIA: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 265
TABLE 262 SOUTH KOREA: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 266
TABLE 263 SOUTH KOREA: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 266
TABLE 264 SOUTH KOREA: PURE MEDICAL GASES MARKET, BY TYPE,
2024–2031 (USD MILLION) 266
TABLE 265 SOUTH KOREA MEDICAL GAS MIXTURES MARKET, BY TYPE,
2024–2031 (USD MILLION) 267
TABLE 266 SOUTH KOREA: MEDICAL GAS EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 267
TABLE 267 SOUTH KOREA: GAS SUPPLY EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 268
TABLE 268 SOUTH KOREA: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 268
TABLE 269 SOUTH KOREA: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 269
TABLE 270 SOUTH KOREA MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 269
TABLE 271 SOUTH KOREA: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 270
TABLE 272 SOUTH KOREA: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 270
TABLE 273 REST OF ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 271
TABLE 274 REST OF ASIA PACIFIC: MEDICAL GASES MARKET, BY TYPE,
2024–2031 (USD MILLION) 271
TABLE 275 REST OF ASIA PACIFIC: PURE MEDICAL GASES MARKET, BY TYPE,
2024–2031 (USD MILLION) 271
TABLE 276 REST OF ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET FOR MEDICAL GAS MIXTURES, BY TYPE, 2024–2031 (USD MILLION) 272
TABLE 277 REST OF ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET FOR MEDICAL GAS EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 272
TABLE 278 REST OF ASIA PACIFIC: GAS SUPPLY EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 273
TABLE 279 REST OF ASIA PACIFIC: GAS REGULATION & MONITORING EQUIPMENT MARKET,
BY TYPE, 2024–2031 (USD MILLION) 273
TABLE 280 REST OF ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 274
TABLE 281 REST OF ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 274
TABLE 282 REST OF ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 275
TABLE 283 REST OF ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 275
TABLE 284 LATIN AMERICA: MEDICAL GAS AND EQUIPMENT MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 276
TABLE 285 LATIN AMERICA: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 276
TABLE 286 LATIN AMERICA: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 276
TABLE 287 LATIN AMERICA: PURE MEDICAL GASES MARKET, BY TYPE,
2024–2031 (USD MILLION) 277
TABLE 288 LATIN AMERICA: MEDICAL GAS MIXTURES MARKET, BY TYPE,
2024–2031 (USD MILLION) 277
TABLE 289 LATIN AMERICA: MEDICAL GAS EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 278
TABLE 290 LATIN AMERICA: GAS SUPPLY EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 278
TABLE 291 LATIN AMERICA: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 279
TABLE 292 LATIN AMERICA: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 279
TABLE 293 LATIN AMERICA: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 280
TABLE 294 LATIN AMERICA: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 280
TABLE 295 LATIN AMERICA: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 281
TABLE 296 BRAZIL: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 282
TABLE 297 BRAZIL: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 282
TABLE 298 BRAZIL: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 282
TABLE 299 BRAZIL: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION) 283
TABLE 300 BRAZIL: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 283
TABLE 301 BRAZIL: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 284
TABLE 302 BRAZIL: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 284
TABLE 303 BRAZIL: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 285
TABLE 304 BRAZIL: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 285
TABLE 305 BRAZIL: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 286
TABLE 306 BRAZIL: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 286
TABLE 307 MEXICO: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 287
TABLE 308 MEXICO: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 287
TABLE 309 MEXICO: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 287
TABLE 310 MEXICO: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION) 288
TABLE 311 MEXICO: MEDICAL GAS EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 288
TABLE 312 MEXICO: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 289
TABLE 313 MEXICO: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 289
TABLE 314 MEXICO: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 290
TABLE 315 MEXICO: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 290
TABLE 316 MEXICO: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 291
TABLE 317 MEXICO: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 291
TABLE 318 REST OF LATIN AMERICA: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 292
TABLE 319 REST OF LATIN AMERICA: MEDICAL GASES MARKET, BY TYPE,
2024–2031 (USD MILLION) 292
TABLE 320 REST OF LATIN AMERICA: PURE MEDICAL GASES MARKET, BY TYPE,
2024–2031 (USD MILLION) 292
TABLE 321 REST OF LATIN AMERICA: MEDICAL GAS MIXTURES MARKET, BY TYPE,
2024–2031 (USD MILLION) 293
TABLE 322 REST OF LATIN AMERICA: MEDICAL GAS EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 293
TABLE 323 REST OF LATIN AMERICA: GAS SUPPLY EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 294
TABLE 324 REST OF LATIN AMERICA: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 294
TABLE 325 REST OF LATIN AMERICA: MEDICAL GAS AND EQUIPMENT MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 295
TABLE 326 REST OF LATIN AMERICA: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 295
TABLE 327 REST OF LATIN AMERICA: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 296
TABLE 328 REST OF LATIN AMERICA MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 296
TABLE 329 MIDDLE EAST & AFRICA: MEDICAL GAS AND EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 297
TABLE 330 MIDDLE EAST & AFRICA: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 297
TABLE 331 MIDDLE EAST & AFRICA: MEDICAL GASES MARKET, BY TYPE,
2024–2031 (USD MILLION) 297
TABLE 332 MIDDLE EAST & AFRICA: PURE MEDICAL GASES MARKET, BY TYPE,
2024–2031 (USD MILLION) 298
TABLE 333 MIDDLE EAST & AFRICA: MEDICAL GAS MIXTURES MARKET, BY TYPE,
2024–2031 (USD MILLION) 298
TABLE 334 MIDDLE EAST & AFRICA: MEDICAL GAS EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 299
TABLE 335 MIDDLE EAST & AFRICA: GAS SUPPLY EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 299
TABLE 336 MIDDLE EAST & AFRICA: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 300
TABLE 337 MIDDLE EAST & AFRICA: MEDICAL GAS AND EQUIPMENT MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 300
TABLE 338 MIDDLE EAST & AFRICA: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 301
TABLE 339 MIDDLE EAST & AFRICA: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 301
TABLE 340 MIDDLE EAST & AFRICA: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 302
TABLE 341 GCC COUNTRIES: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 302
TABLE 342 GCC COUNTRIES: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 303
TABLE 343 GCC COUNTRIES: PURE MEDICAL GASES MARKET, BY TYPE,
2024–2031 (USD MILLION) 303
TABLE 344 GCC COUNTRIES: MEDICAL GAS MIXTURES MARKET, BY TYPE,
2024–2031 (USD MILLION) 304
TABLE 345 GCC COUNTRIES: MEDICAL GAS EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 304
TABLE 346 GCC COUNTRIES: GAS SUPPLY EQUIPMENT MARKET, BY TYPE,
2024–2031 (USD MILLION) 305
TABLE 347 GCC COUNTRIES: GAS REGULATION & MONITORING EQUIPMENT MARKET,
BY TYPE, 2024–2031 (USD MILLION) 305
TABLE 348 GCC COUNTRIES: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 306
TABLE 349 GCC COUNTRIES: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 306
TABLE 350 GCC COUNTRIES: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 307
TABLE 351 GCC COUNTRIES: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER,
2024–2031 (USD MILLION) 307
TABLE 352 REST OF MIDDLE EAST & AFRICA: MEDICAL GAS AND EQUIPMENT MARKET,
BY TYPE, 2024–2031 (USD MILLION) 308
TABLE 353 REST OF MIDDLE EAST & AFRICA: MEDICAL GASES MARKET, BY TYPE,
2024–2031 (USD MILLION) 308
TABLE 354 REST OF MIDDLE EAST & AFRICA: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION) 308
TABLE 355 REST OF MIDDLE EAST & AFRICA: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION) 309
TABLE 356 REST OF MIDDLE EAST & AFRICA: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 309
TABLE 357 REST OF MIDDLE EAST & AFRICA: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 310
TABLE 358 REST OF MIDDLE EAST & AFRICA: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 310
TABLE 359 REST OF MIDDLE EAST & AFRICA: MEDICAL GAS AND EQUIPMENT MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 311
TABLE 360 REST OF MIDDLE EAST & AFRICA: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 311
TABLE 361 REST OF MIDDLE EAST & AFRICA: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 312
TABLE 362 REST OF MIDDLE EAST & AFRICA: MEDICAL GAS AND EQUIPMENT MARKET,
BY END USER, 2024–2031 (USD MILLION) 312
TABLE 363 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN MEDICAL GAS AND EQUIPMENT MARKET 313
TABLE 364 MEDICAL GAS AND EQUIPMENT MARKET: DEGREE OF COMPETITION 316
TABLE 365 MEDICAL GAS AND EQUIPMENT MARKET: REGION FOOTPRINT 321
TABLE 366 MEDICAL GAS AND EQUIPMENT MARKET: TYPE FOOTPRINT 322
TABLE 367 MEDICAL GAS AND EQUIPMENT MARKET: APPLICATION FOOTPRINT 323
TABLE 368 MEDICAL GAS AND EQUIPMENT MARKET: END-USER FOOTPRINT 324
TABLE 369 MEDICAL GAS AND EQUIPMENT MARKET: DETAILED LIST OF KEY STARTUPS/SMES 328
TABLE 370 MEDICAL GAS AND EQUIPMENT MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 329
TABLE 371 MEDICAL GAS AND EQUIPMENT MARKET: DEALS, JANUARY 2021–JUNE 2026 332
TABLE 372 MEDICAL GAS AND EQUIPMENT MARKET: EXPANSIONS,
JANUARY 2021–JUNE 2026 333
TABLE 373 MEDICAL GAS AND EQUIPMENT MARKET: OTHER DEVELOPMENTS,
JANUARY 2021–JUNE 2026 333
TABLE 374 LINDE PLC: COMPANY OVERVIEW 334
TABLE 375 LINDE PLC: PRODUCTS OFFERED 335
TABLE 376 LINDE PLC: EXPANSIONS, JANUARY 2021–JUNE 2026 336
TABLE 377 AIR LIQUIDE: COMPANY OVERVIEW 338
TABLE 378 AIR LIQUIDE: PRODUCTS OFFERED 339
TABLE 379 AIR LIQUIDE: DEALS, JANUARY 2021–JUNE 2026 341
TABLE 380 AIR LIQUIDE: EXPANSIONS, JANUARY 2021–JUNE 2026 341
TABLE 381 AIR LIQUIDE: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2026 342
TABLE 382 MESSER SE & CO. KGAA: COMPANY OVERVIEW 343
TABLE 383 MESSER SE & CO. KGAA: PRODUCTS OFFERED 344
TABLE 384 MESSER SE & CO. KGAA: DEALS, JANUARY 2021–JUNE 2026 345
TABLE 385 MESSER SE & CO. KGAA: EXPANSIONS, JANUARY 2021–JUNE 2026 345
TABLE 386 AIR PRODUCTS AND CHEMICALS, INC.: COMPANY OVERVIEW 347
TABLE 387 AIR PRODUCTS AND CHEMICALS, INC.: PRODUCTS OFFERED 348
TABLE 388 NIPPON SANSO HOLDINGS CORPORATION: COMPANY OVERVIEW 350
TABLE 389 NIPPON SANSO HOLDINGS CORPORATION: PRODUCTS OFFERED 351
TABLE 390 NIPPON SANSO HOLDINGS CORPORATION: DEALS, JANUARY 2021–JUNE 2026 352
TABLE 391 ATLAS COPCO AB: COMPANY OVERVIEW 353
TABLE 392 ATLAS COPCO AB: PRODUCTS OFFERED 354
TABLE 393 ATLAS COPCO AB: DEALS, JANUARY 2021–JUNE 2026 355
TABLE 394 GCE GROUP: COMPANY OVERVIEW 357
TABLE 395 GCE GROUP: PRODUCTS OFFERED 357
TABLE 396 GCE GROUP: DEALS, JANUARY 2021–JUNE 2026 359
TABLE 397 SOL SPA: COMPANY OVERVIEW 360
TABLE 398 SOL SPA: PRODUCTS OFFERED 361
TABLE 399 SOL SPA: DEALS, JANUARY 2021–JUNE 2026 362
TABLE 400 MEDTRONIC PLC: EXPANSIONS, JANUARY 2021–JUNE 2026 363
TABLE 401 ROTAREX: COMPANY OVERVIEW 364
TABLE 402 ROTAREX: PRODUCTS OFFERED 364
TABLE 403 NORCO INC.: COMPANY OVERVIEW 367
TABLE 404 NORCO INC.: PRODUCTS OFFERED 367
TABLE 405 GENSTAR TECHNOLOGIES: COMPANY OVERVIEW 368
TABLE 406 GENSTAR TECHNOLOGIES: PRODUCTS OFFERED 368
TABLE 407 SOUTHERN GAS LIMITED: COMPANY OVERVIEW 371
TABLE 408 SOUTHERN GAS LIMITED: PRODUCTS OFFERED 372
TABLE 409 DRÄGERWERK AG & CO. KGAA: COMPANY OVERVIEW 373
TABLE 410 DRÄGERWERK AG & CO. KGAA: PRODUCTS OFFERED 375
TABLE 411 CALOX INC.: COMPANY OVERVIEW 376
TABLE 412 CALOX INC.: PRODUCTS OFFERED 376
TABLE 413 PT SAMATOR INDO GAS TBK: COMPANY OVERVIEW 377
TABLE 414 PT SAMATOR INDO GAS TBK: PRODUCTS OFFERED 378
TABLE 415 BUTLER GAS PRODUCTS COMPANY: COMPANY OVERVIEW 380
TABLE 416 AMICO GROUP OF COMPANIES: COMPANY OVERVIEW 381
TABLE 417 AIMS OXYGEN PVT LTD. (AOPL): COMPANY OVERVIEW 382
TABLE 418 APEX MEDICAL GAS INC.: COMPANY OVERVIEW 383
TABLE 419 CHENGDU TAIYO INDUSTRIAL GASES CO., LTD.: COMPANY OVERVIEW 384
TABLE 420 STEELMAN GASES PVT. LTD.: COMPANY OVERVIEW 385
TABLE 421 CARBIDE AND CHEMICALS: COMPANY OVERVIEW 386
TABLE 422 HOLSTON GASES: COMPANY OVERVIEW 387
TABLE 423 MEC MEDICAL LTD.: COMPANY OVERVIEW 388
TABLE 424 PRECISION UK: COMPANY OVERVIEW 389
TABLE 425 RISK ASSESSMENT: MEDICAL GAS AND EQUIPMENT MARKET 401

LIST OF FIGURES

FIGURE 1 MEDICAL GAS AND EQUIPMENT MARKET SEGMENTATION & REGIONAL SCOPE 36
FIGURE 2 MEDICAL GAS AND EQUIPMENT MARKET: YEARS CONSIDERED 37
FIGURE 3 KEY INSIGHTS & MARKET HIGHLIGHTS 40
FIGURE 4 MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION) 40
FIGURE 5 PURE MEDICAL GASES MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION) 41
FIGURE 6 MEDICAL GAS MIXTURES MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION) 42
FIGURE 7 MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION) 43
FIGURE 8 GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION) 43
FIGURE 9 GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE,
2026 VS. 2031 (USD MILLION) 44
FIGURE 10 MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION,
2026 VS. 2031 (USD MILLION) 44
FIGURE 11 MEDICAL GAS AND EQUIPMENT MARKET, BY END USER,
2026 VS. 2031 (USD MILLION) 45
FIGURE 12 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL GAS AND EQUIPMENT MARKET 45
FIGURE 13 DISRUPTIVE TRENDS IMPACTING GROWTH OF MEDICAL GAS AND EQUIPMENT MARKET 46
FIGURE 14 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN MEDICAL GAS AND EQUIPMENT MARKET 47
FIGURE 15 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 48
FIGURE 16 INCREASING HEALTHCARE EXPENDITURE AND PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET 49
FIGURE 17 JAPAN AND MEDICAL GASES SEGMENT DOMINATED MARKET IN 2025 50
FIGURE 18 NORTH AMERICA TO LEAD MARKET DURING FORECAST PERIOD 51
FIGURE 19 INDIA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 51
FIGURE 20 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 52
FIGURE 21 MEDICAL GAS AND EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 53
FIGURE 22 GLOBAL GERIATRIC POPULATION, BY REGION, 2010 VS. 2015 VS.
2030 (% OF TOTAL POPULATION) 55
FIGURE 23 PREVALENCE OF CHRONIC PAIN AND HIGH-IMPACT CHRONIC PAIN AMONG ADULTS IN US, 2019–2021 57
FIGURE 24 MEDICAL GAS AND EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 65
FIGURE 25 MEDICAL GAS AND EQUIPMENT MARKET: SUPPLY CHAIN ANALYSIS 70
FIGURE 26 MEDICAL GAS AND EQUIPMENT MARKET: VALUE CHAIN ANALYSIS 71
FIGURE 27 MEDICAL GAS AND EQUIPMENT MARKET: ECOSYSTEM ANALYSIS 72
FIGURE 28 MEDICAL GAS AND EQUIPMENT MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 76
FIGURE 29 INVESTMENT/VENTURE CAPITAL SCENARIO IN MEDICAL GAS AND EQUIPMENT MARKET, 2020–2023 77
FIGURE 30 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR MEDICAL GAS AND EQUIPMENT MARKET (JANUARY 2016–MAY 2026) 89
FIGURE 31 TOP PATENT APPLICANT COUNTRIES FOR MEDICAL GAS AND EQUIPMENT (JANUARY 2016–MAY 2026) 90
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL GAS AND EQUIPMENT, BY TYPE 104
FIGURE 33 KEY BUYING CRITERIA FOR MEDICAL GAS AND EQUIPMENT, BY TYPE 105
FIGURE 34 NORTH AMERICA: MEDICAL GAS AND EQUIPMENT MARKET SNAPSHOT 186
FIGURE 35 ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET SNAPSHOT 239
FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL GAS AND EQUIPMENT MARKET (2021−2025) 315
FIGURE 37 MARKET SHARE ANALYSIS OF KEY PLAYERS IN MEDICAL GAS AND EQUIPMENT MARKET (2025) 316
FIGURE 38 MEDICAL GAS AND EQUIPMENT MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2025 319
FIGURE 39 MEDICAL GAS AND EQUIPMENT MARKET: COMPANY FOOTPRINT 320
FIGURE 40 MEDICAL GAS AND EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 327
FIGURE 41 MEDICAL GAS AND EQUIPMENT MARKET: BRAND/PRODUCT COMPARISON 330
FIGURE 42 EV/EBITDA OF KEY VENDORS 331
FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDOR 331
FIGURE 44 LINDE PLC: COMPANY SNAPSHOT (2025) 335
FIGURE 45 AIR LIQUIDE: COMPANY SNAPSHOT (2025) 339
FIGURE 46 MESSER SE & CO. KGAA: COMPANY SNAPSHOT (2025) 344
FIGURE 47 AIR PRODUCTS AND CHEMICALS, INC.: COMPANY SNAPSHOT (2025) 348
FIGURE 48 NIPPON SANSO HOLDINGS CORPORATION: COMPANY SNAPSHOT (2025) 350
FIGURE 49 ATLAS COPCO AB: COMPANY SNAPSHOT (2025) 354
FIGURE 50 SOL SPA: COMPANY SNAPSHOT (2025) 361
FIGURE 51 SOUTHERN GAS LIMITED: COMPANY SNAPSHOT (2025) 371
FIGURE 52 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2025) 374
FIGURE 53 PT SAMATOR INDO GAS TBK: COMPANY SNAPSHOT (2025) 378
FIGURE 54 RESEARCH DESIGN 390
FIGURE 55 PRIMARY SOURCES 392
FIGURE 56 BOTTOM-UP APPROACH 394
FIGURE 57 TOP-DOWN APPROACH 394
FIGURE 58 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 395
FIGURE 59 REVENUE SHARE ANALYSIS ILLUSTRATION: LINDE PLC 396
FIGURE 60 MEDICAL GAS AND EQUIPMENT MARKET: SUPPLY-SIDE MARKET ESTIMATION (2025) 397
FIGURE 61 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 398
FIGURE 62 MARKET DATA TRIANGULATION METHODOLOGY 399

---

---